S. Dias

Target Trial Emulation for Transparent and Robust Estimation of Treatment Effects for Health Technology Assessment Using Real-World Data: Opportunities and Challenges

N. Freemantle, G. Baio, R. Grieve, 2022, PharmacoEconomics.

Using individual participant data to improve network meta-analysis projects

David M. Phillippo, L. Stewart, R. Riley, 2022, BMJ Evidence-Based Medicine.

Exploring Heterogeneity in Histology-Independent Technologies and the Implications for Cost-Effectiveness

S. Palmer, A. Llewellyn, R. Hodgson, 2021, Medical decision making : an international journal of the Society for Medical Decision Making.

Appraising the Costs of Genomic Testing for Histology-Independent Technologies: An Illustrative Example for NTRK Fusions.

R. Metcalf, R. Hodgson, M. Walton, 2021, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: systematic reviews and economic evaluation.

S. Walker, S. Palmer, M. Soares, 2020, Health technology assessment.

Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.

S. Palmer, P. Tappenden, M. Stevenson, 2021, Health technology assessment.

The effectiveness of ablative and non‐surgical therapies for early hepatocellular carcinoma: Systematic review and network meta‐analysis of randomised controlled trials

M. Harden, R. Wade, Sumayya Anwer, 2023, Cancer medicine.

Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.

M. Harden, R. Wade, Sumayya Anwer, 2023, Health technology assessment.